Analyst firms · J.P. Morgan · VIR

J.P. Morgan VIR price target and rating history

Vir Biotechnology Inc. (VIR) · Health Care

J.P. Morgan rates Vir Biotechnology Inc. (VIR) Neutral with a $9 price target, as of its latest action on Jan 29, 2024. It has published 3 rating actions on VIR since October 2021, including 2 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$9
Median target, all firms
Too few
Actions on VIR
3

J.P. Morgan price target on VIR

$37$23$920222023202420252026
J.P. Morgan price target on VIR, each point a stated target, October 2021 to January 2024.

Every J.P. Morgan rating on VIR

Questions about J.P. Morgan and VIR

What is J.P. Morgan's price target for VIR?
J.P. Morgan's latest stated price target for Vir Biotechnology Inc. (VIR) is $9, from its action on Jan 29, 2024.
What is J.P. Morgan's rating on VIR?
J.P. Morgan rates VIR Neutral, a neutral rating, as of Jan 29, 2024.
When did J.P. Morgan last change its view on VIR?
On Jan 29, 2024, J.P. Morgan downgrades to Neutral from Overweight, price target $23 to $9.

More VIR rating histories

All J.P. Morgan ratingsVIR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.